Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 2/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9624718 | 0.91 | TSHR (0.46) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL2095250 | 0.91 | TSHR (0.46) | HIF1ATSHRFAAHTRPV1ALDH1A1 | |
| SCHEMBL2096128 | 0.84 | — | — | |
| SCHEMBL10949134 | 0.79 | TSHR (0.42) | HIF1ATSHRMAPTFAAHTRPV1 | |
| SCHEMBL10943870 | 0.78 | HIF1A (0.36) | HIF1ATSHRMAPTFAAHTRPV1 | |
| SCHEMBL12526532 | 0.76 | HIF1A (0.35) | HIF1ATSHRMAPT | |
| SCHEMBL30750305 | 0.76 | HIF1A (0.35) | HIF1ATSHRMAPT | |
| SCHEMBL12403539 | 0.75 | TSHR (0.42) | TSHRALDH1A1 | |
| SCHEMBL7242764 | 0.75 | — | — | |
| SCHEMBL20565698 | 0.75 | HIF1A (0.43) | HIF1ATSHRMAPTFAAHTRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0024532-B2 | TERT. BUTOXYBUTANALES AND BUTANOLES AND BIS-TERT. BUTOXY-PENTANALES AND PENTANOLES, THEIR PRODUCTION AND THEIR USE AS PERFUMES | BASF Aktiengesellschaft (DE) | 1984-08-15 | — | — | EP | claimed |
| US-4414420-A | CATALYTIC HYDROFORMYLATION OF CORRESPONDING UNSATURATED ETHER | DAVY MCKEE (OIL & CHEMICALS) LIMITED (GB) | 1983-11-08 | — | — | US | claimed |
| EP-0018161-B1 | ALDEHYDE-ETHERS AND PROCESS FOR THEIR PRODUCTION | DAVY McKEE (LONDON) LIMITED (GB) | 1983-05-25 | — | — | EP | claimed |
| US-4383125-A | CHEMICAL INTERMEDIATES FOR 6-BUTYROLACTONE, 1,4-BUTANEDIOL, AND TETRAHYDROFURAN | DAVY MCKEE (OIL & CHEMICALS) LIMITED (GB) | 1983-05-10 | — | — | US | claimed |
| EP-0024532-B1 | TERT. BUTOXYBUTANALES AND BUTANOLES AND BIS-TERT. BUTOXY-PENTANALES AND PENTANOLES, THEIR PRODUCTION AND THEIR USE AS PERFUMES | BASF Aktiengesellschaft (DE) | 1982-06-23 | — | — | EP | claimed |
| EP-0024532-A1 | Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | claimed |
| EP-0018161-A1 | Aldehyde-ethers and process for their production | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | claimed |
| WO-2020015698-A1 | METHOD FOR PREPARING COAGULATION FACTOR XIA INHIBITOR AND INTERMEDIATE THEREOF | 江苏恒瑞医药股份有限公司 | 2020-01-23 | — | — | WO | disclosed |
| US-9670232-B2 | Molecular precursor compounds for zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-9455142-B2 | Molecular precursor compounds for ABIGZO zinc-group 13 mixed oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-09-27 | — | — | US | disclosed |
| US-9404002-B2 | Molecular precursor compounds for indium gallium zinc oxide materials | TRANSTRON SOLUTIONS LLC (US) | 2016-08-02 | — | — | US | disclosed |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | PRECURSOR ENERGETICS, INC. (US) | 2015-08-06 | — | — | US | disclosed |
| EP-0024532-A1 | Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | disclosed |
| EP-0024532-A1 | Tert. butoxybutanales and butanoles and bis-tert. butoxy-pentanales and pentanoles, their production and their use as perfumes | BASF Aktiengesellschaft (DE) | 1981-03-11 | — | — | EP | disclosed |
| EP-0018164-A1 | Production of tetrahydrofuran | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | disclosed |
| EP-0018161-A1 | Aldehyde-ethers and process for their production | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | disclosed |
| EP-0018161-A1 | Aldehyde-ethers and process for their production | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | disclosed |
| EP-0018163-A1 | Production of butane-1,4-diol | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | disclosed |
| EP-0018162-A1 | Production of butyrolactone | DAVY McKEE (LONDON) LIMITED (GB) | 1980-10-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150221772-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ABIZO ZINC-GROUP 13 MIXED OXIDE MATERIALS | IKZF3, ZRANB2, ZFR | HIF1A 2494/4885TSHR 3832/4885MAPT 1589/4885 |
| US-20150218190-A1 | MOLECULAR PRECURSOR COMPOUNDS FOR ZINC-GROUP 13 MIXED OXIDE MATERIALS | ZFR, ZRANB2, IKZF3 | HIF1A 3821/4885TSHR 3366/4885MAPT 2504/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.